LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 87 filers reported holding LION BIOTECHNOLOGIES INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $25,740,000 | -6.5% | 3,455,044 | -12.8% | 6.10% | -40.4% |
| Q4 2016 | $27,522,000 | +3.5% | 3,959,944 | +22.6% | 10.24% | +2.5% |
| Q3 2016 | $26,582,000 | +1.5% | 3,229,916 | -0.1% | 9.98% | -20.7% |
| Q2 2016 | $26,183,000 | +106.2% | 3,232,416 | +29.3% | 12.58% | +77.2% |
| Q1 2016 | $12,700,000 | -14.1% | 2,500,000 | +30.5% | 7.10% | +0.4% |
| Q4 2015 | $14,784,000 | +95.2% | 1,915,000 | +45.6% | 7.07% | +61.3% |
| Q3 2015 | $7,574,000 | -6.8% | 1,314,959 | +48.4% | 4.38% | -12.7% |
| Q2 2015 | $8,125,000 | +0.3% | 886,000 | +32.4% | 5.02% | -26.4% |
| Q1 2015 | $8,104,000 | – | 669,196 | – | 6.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,229,916 | $26,582,000 | 9.98% |
| FRAZIER MANAGEMENT LLC | 2,087,281 | $17,178,000 | 8.43% |
| Avoro Capital Advisors LLC | 4,257,347 | $35,038,000 | 6.15% |
| Broadfin Capital, LLC | 2,638,259 | $21,713,000 | 1.95% |
| Perceptive Advisors | 3,567,553 | $29,360,000 | 1.90% |
| Opaleye Management Inc. | 280,000 | $2,304,000 | 1.21% |
| Ghost Tree Capital, LLC | 825,000 | $6,790,000 | 1.10% |
| Rhenman & Partners Asset Management AB | 650,000 | $5,349,500,000 | 0.85% |
| QVT Financial LP | 1,751,509 | $14,335,000 | 0.54% |
| Cormorant Asset Management, LP | 505,941 | $4,164,000 | 0.46% |